Feasibility and acceptability of G6PD testing and radical cure for Plasmodium vivax in Cambodia: the VIGTARC study

Patients diagnosed with P.v infection by Village Malaria Workers (VMWs) were referred to local health centres for point-of-care G6PD testing and initiation of radical cure treatment depending on G6PD status. Primaquine was administered as 14 daily doses or 8 weekly doses of primaquine depending on G6PD status, with counselling and community follow-up including directly observed therapy by the VMW.

Feasibility and acceptability were evaluated using a mixed methods approach.